In November 2020, Evestra, Inc. received a grant from the Bill and Melinda Gates Foundation to develop a twice-yearly injectable contraceptive. The goal of this project is to enable greater access to modern contraceptives for women in undeserved regions such as Sub-Saharan Africa, who desire convenient and affordable methods to plan their families.
“We are incredibly excited for this partnership and that we share the Foundation’s concern that more than 220 million women who don’t want to get pregnant and live in developing countries lack access to fertility control and voluntary family planning information and services,” said Ze’ev Shaked, Ph.D, Evestra’s President and CEO. “
With less than 20 percent of women using modern fertility control in those regions, Evestra’s partnership with the Gates Foundation will set the tone for the future of women’s health within Evestra’s portfolio and in different regions across the world. With Evestra’s mission of improving the health and well-being of women around the world by applying innovative technologies and products, we are hopeful that this partnership gives women and their families the ability to live their lives in confidence.